Company page

Moleculin Biotech, Inc.

Moleculin Biotech, Inc. (ticker: MBRX) is a public company based in America, focusing on the development of innovative therapies for cancer treatment. The company has a market capitalization of approximately $15.37 million. Moleculin is dedicated to advancing its drug candidates through various stages of clinical development to address unmet medical needs in oncology.